Wed, April 15, 2009
[ Wed, Apr 15th 2009 ] - Market Wire
The Medicines Company: The Medicines Company to A .. 09 Financial Results on Wednesday, April 29, 2009
[ Wed, Apr 15th 2009 ] - Market Wire
Forbes Medi-Tech Inc.: Forbes Medi-Tech Provides Update on NASDAQ Listing
[ Wed, Apr 15th 2009 ] - Market Wire
Anaconda Mining Inc.: Anaconda Mining Announces Q3, 2009 Results
[ Wed, Apr 15th 2009 ] - Market Wire
Lakeland Industries, Inc.: Lakeland Industries, I .. arter and Full Fiscal Year 2009 Financial Results
[ Wed, Apr 15th 2009 ] - Market Wire
Adeona Pharmaceuticals, Inc.: Adeona Appoints Dav .. Newsome, M.D., President of HealthMine Subsidiary
[ Wed, Apr 15th 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. arter 2009 Results and Conduct Conference Call on
Tue, April 14, 2009
[ Tue, Apr 14th 2009 ] - Market Wire
Medical Nutrition USA, Inc.: Medical Nutrition Na .. ert Mathias Vice President, Sales & Marketing
[ Tue, Apr 14th 2009 ] - Market Wire
Paradigm Medical Industries Inc.: Paradigm Medica .. OI for Up to $1.8 Million in Structured Financing
[ Tue, Apr 14th 2009 ] - Market Wire
Proton Laboratories Inc.: Proton Laboratories in Discussions for Chinese Distribution
[ Tue, Apr 14th 2009 ] - Market Wire
Medical Nutrition USA, Inc.: Medical Nutrition US .. rth-Quarter and Year-End Results and Conduct a Co
[ Tue, Apr 14th 2009 ] - Market Wire
Vyteris, Inc.: Vyteris and Zealand Pharma Announc .. ent on Active Transdermal Patch for Peptide Drugs
[ Tue, Apr 14th 2009 ] - Market Wire
Marani Spirits: Marani Brands Moves Into Nevada
Mon, April 13, 2009
[ Mon, Apr 13th 2009 ] - Market Wire
Stellar Pharmaceuticals Inc.: Stellar Pharmaceuticals Cash Positive for 2008
[ Mon, Apr 13th 2009 ] - Market Wire
Atlantis Systems Corp.: Atlantis Systems Corporation Announces Re-Pricing of Warrants
[ Mon, Apr 13th 2009 ] - Market Wire
Cytokinetics, Inc.: Cytokinetics Announces Non-Cl .. 17357 to Be Presented at the 2009 Experimental Bi
[ Mon, Apr 13th 2009 ] - Market Wire
Nanobac Pharmaceuticals, Inc.: Nanobac Pharmaceuticals and Eureka Genomics Sign Merger Agreement
[ Mon, Apr 13th 2009 ] - Market Wire
Diagnostic Imaging International Corp.: Diagnosti .. ng International Corp.-CTS Signs 10 New Hospitals
Fri, April 10, 2009
[ Fri, Apr 10th 2009 ] - Market Wire
FORTIS: Fortis holding statement on ruling by Court of Appeal of Brussels
[ Fri, Apr 10th 2009 ] - Market Wire
Lakeland Industries, Inc.: Lakeland Industries to .. and Year End Results and Hold Conference Call on
[ Fri, Apr 10th 2009 ] - Market Wire
MDRNA, Inc.: MDRNA, Inc. Complies With NASDAQ Marketplace Rule 4350(b)(1)(B)
Thu, April 9, 2009
[ Thu, Apr 09th 2009 ] - Market Wire
Adeona Pharmaceuticals, Inc.: Adeona Launches Cop .. Awareness of the Risks of Chronic Copper Toxicity
[ Thu, Apr 09th 2009 ] - Market Wire
Smith & Nephew Plc: Smith & Nephew Plc: Annual Information Update
[ Thu, Apr 09th 2009 ] - Market Wire
Stellar Pharmaceuticals Inc.: Stellar Pharmaceuticals Inc. Announces Normal Course Issuer Bid
[ Thu, Apr 09th 2009 ] - Market Wire
Adeona Pharmaceuticals, Inc.: Adeona Pharmaceuticals to Host Webcast Today at 2pm ET, April 9th
[ Thu, Apr 09th 2009 ] - Market Wire
Marani Brands, Inc.: Marani Brands Distribution I .. essful Execution of Marketing and Events Strategy
[ Thu, Apr 09th 2009 ] - Market Wire
Smith & Nephew Plc: Smith & Nephew: Notice of Results
Wed, April 8, 2009
[ Wed, Apr 08th 2009 ] - Market Wire
Myriad Pharmaceuticals, Inc.: Myriad Pharmaceuticals Receives IND Approval for New Cancer Drug
[ Wed, Apr 08th 2009 ] - Market Wire
CONMED Corporation: CONMED Corporation to Announc .. Quarter 2009 Financial Results on April 23, 2009
[ Wed, Apr 08th 2009 ] - Market Wire
Atlantis Systems Corp.: Atlantis Systems Corp. Wi .. $1.9M Contract With L-3 Communications MAPPS Inc.
[ Wed, Apr 08th 2009 ] - Market Wire
Cavit Sciences, Inc.: Cavit Sciences Signs Letter of Intent
[ Wed, Apr 08th 2009 ] - Market Wire
Orex Minerals Inc.: Orex Hits 6 Kilograms Silver .. on Zambranena Vein, Diamond Drilling to Commence
[ Wed, Apr 08th 2009 ] - Market Wire
Encision: Encision Signs a Non-Exclusive Manufact .. y and Licensing Agreement With Intuitive Surgical
Tue, April 7, 2009
[ Tue, Apr 07th 2009 ] - Market Wire
Paradigm Medical Industries, Inc.: Paradigm Medic .. Industries Announces New President, Stephen Davis
[ Tue, Apr 07th 2009 ] - Market Wire
Adeona Pharmaceuticals, Inc.: Adeona Pharmaceuticals Announces Stock Repurchase Program
[ Tue, Apr 07th 2009 ] - Market Wire
Somatic Systems, Inc.: Somatic Systems, Inc. Releases Annual Review Letter to Shareholders
[ Tue, Apr 07th 2009 ] - Market Wire
HearUSA: HearUSA Reports Revenues for First Quarter 2009
Mon, April 6, 2009
[ Mon, Apr 06th 2009 ] - Market Wire
Theravance, Inc.: Theravance Announces FDA Accept .. for the Treatment of Hospital-Acquired Pneumonia
[ Mon, Apr 06th 2009 ] - Market Wire
Bennett Environmental Inc.: CORRECTION FROM SOURC .. Announces Beginning of New Saint Ambroise Campai
[ Mon, Apr 06th 2009 ] - Market Wire
Facet Biotech Corporation: Facet Biotech Responds to Roderick Wong Letter and Press Release
[ Mon, Apr 06th 2009 ] - Market Wire
CTD Holdings, Inc.: CTD Holdings Adds New Member to the Board of Directors
[ Mon, Apr 06th 2009 ] - Market Wire
Allana Resources Inc.: Allana Resources Completes .. naissance Exploration at Ethiopian Potash Project
[ Mon, Apr 06th 2009 ] - Market Wire
Edwards Lifesciences: Edwards Lifesciences Launch .. ystem to Enhance Performance in Patients With Sep
Fri, April 3, 2009
[ Fri, Apr 03rd 2009 ] - Market Wire
TLCVision Corporation: TLCVision Secures Credit Facility Limited Waiver
[ Fri, Apr 03rd 2009 ] - Market Wire
Big Stick Media Corporation: Big Stick Media Corp .. Intention to Re-Schedule Debt Payment Obligations
[ Fri, Apr 03rd 2009 ] - Market Wire
MedLink International: CMS Selects MedLink to Participate in PQRI 2009 EHR Testing Program
[ Fri, Apr 03rd 2009 ] - Market Wire
MoneyTV; Empire Energy Corporation Intl.; Platinu .. inOil, Inc.; Imaging3, Inc.: MoneyTV, Week of 4/3
Thu, April 2, 2009
[ Thu, Apr 02nd 2009 ] - Market Wire
The Medicines Company: The Medicines Company Anno .. Option Grants Under NASDAQ Marketplace Rule 4350
[ Thu, Apr 02nd 2009 ] - Market Wire
Constellation Software Inc.: Capital Area Transpo .. lects Constellation Software's Trapeze Subsidiary
[ Thu, Apr 02nd 2009 ] - Market Wire
DelSite, Inc.: DelSite, Inc. Announces Bankruptcy Filing
[ Thu, Apr 02nd 2009 ] - Market Wire
Allied Healthcare: Allied Healthcare International Inc. Adopts Shareholder Rights Plan
[ Thu, Apr 02nd 2009 ] - Market Wire
Health This Week with Don Baillargeon; Imaging3, .. , Inc.: Health This Week With Don Baillargeon, 4/
[ Thu, Apr 02nd 2009 ] - Market Wire
Stem Cell Therapy International, Inc.: Stem Cell .. Soon to Be "AmStem") Announces New Stem
Wed, April 1, 2009
[ Wed, Apr 01st 2009 ] - Market Wire
Clearant, Inc.: Clearant, Inc. Reports Record 2008 Revenue Results
[ Wed, Apr 01st 2009 ] - Market Wire
FORTIS: Fortis holding changes agendas of General .. ers on 8 and 9 April, and on 28 and 29 April 2009
[ Wed, Apr 01st 2009 ] - Market Wire
IDO Security, Inc.: IDO Security in Negotiations .. oe for Security During the Soccer World Cup in 20
[ Wed, Apr 01st 2009 ] - Market Wire
MDRNA, Inc.: MDRNA, Inc. Sells Contract Manufacturing Operation
[ Wed, Apr 01st 2009 ] - Market Wire
Adeona Pharmaceuticals, Inc.: Adeona Pharmaceutic .. nnounces Fourth Quarter and Year End 2008 Results
Tue, March 31, 2009
[ Tue, Mar 31st 2009 ] - Market Wire
Targeted Genetics: Targeted Genetics Corporation .. ourth Quarter and Year-End 2008 Financial Results
[ Tue, Mar 31st 2009 ] - Market Wire
Facet Biotech: Facet Biotech Receives Director Nomination Notice
[ Tue, Mar 31st 2009 ] - Market Wire
Stem Cell Therapy International, Inc.: Stem Cell .. Soon to Be "AmStem") Ready to Replicate
[ Tue, Mar 31st 2009 ] - Market Wire
AVI BioPharma, Inc.: AVI BioPharma Appoints Drs. .. and M. Kathleen Behrens to Its Board of Directors
[ Tue, Mar 31st 2009 ] - Market Wire
SciClone Pharmaceuticals: SciClone and Sigma Tau .. rector Election Contest for 2009 Annual Meeting o
[ Tue, Mar 31st 2009 ] - Market Wire
Skyepharma PLC: Skyepharma - Re Agreement
Mon, March 30, 2009
[ Mon, Mar 30th 2009 ] - Market Wire
FORTIS: Fortis: Results full year 2008
[ Mon, Mar 30th 2009 ] - Market Wire
MedaSorb Technologies Corporation: CytoSorbents, .. pany Most Likely to Succeed" at the 2009 New
[ Mon, Mar 30th 2009 ] - Market Wire
Corcept Therapeutics: Corcept Therapeutics Announ .. ear 2008 Results and Update on Development Progra
[ Mon, Mar 30th 2009 ] - Market Wire
Adherex Technologies Inc.: Adherex Reports 2008 Fiscal Results
[ Mon, Mar 30th 2009 ] - Market Wire
Cytokinetics, Inc.: Cytokinetics Announces Final .. ta for CK-1827452 Presented at the 2009 Annual Sc
[ Mon, Mar 30th 2009 ] - Market Wire
Cypress Bioscience, Inc.: Cypress Bioscience, Inc. to Present at Citi's 4th Annual Biotech Day
Fri, March 27, 2009
[ Fri, Mar 27th 2009 ] - Market Wire
FORTIS: Fortis reaction on decisions of former subsidiairies not to call hybrid instruments
[ Fri, Mar 27th 2009 ] - Market Wire
Gamma Pharmaceuticals Inc.: Gamma Pharmaceuticals .. as Distributor Worth $1,500,000 Retail Market Val
Thu, March 26, 2009
[ Thu, Mar 26th 2009 ] - Market Wire
HearUSA: HearUSA Reports Fourth Quarter and Fiscal 2008 Results
[ Thu, Mar 26th 2009 ] - Market Wire
DIANOR RESOURCES INC.: Dianor Resources Inc.: Leadbetter Bulk Sampling Plans Filed With MNDM
[ Thu, Mar 26th 2009 ] - Market Wire
AMI Research: AMI Research Updates Q4 Stock Report of NeoGenomics, Inc.
[ Thu, Mar 26th 2009 ] - Market Wire
The Medicines Company: The Medicines Company EU F .. viprex(R) for the Treatment of Acute Hypertension
[ Thu, Mar 26th 2009 ] - Market Wire
BIOLASE Technology, Inc.: BIOLASE and NLT Announce Settlement Agreement
[ Thu, Mar 26th 2009 ] - Market Wire
BIOLASE Technology, Inc.: BIOLASE Receives Deficiency Letter From NASDAQ
Wed, March 25, 2009
[ Wed, Mar 25th 2009 ] - Market Wire
Molecular Insight Pharmaceuticals, Inc. : Molecul .. Detailed Phase 2 Trial Results Demonstrating Abi
[ Wed, Mar 25th 2009 ] - Market Wire
Vyteris, Inc.: Vyteris Announces Agreement for Additional Funding
Tue, March 24, 2009
[ Tue, Mar 24th 2009 ] - Market Wire
Myriad Genetics: Myriad Applauds New ACOG Guidelines for Hereditary Breast and Ovarian Cancer
[ Tue, Mar 24th 2009 ] - Market Wire
Cavit Sciences, Inc.: Cavit Sciences in Negotiati .. re Web Portal Company for Healthy Living/Wellness
Mon, March 23, 2009
[ Mon, Mar 23rd 2009 ] - Market Wire
Cytokinetics, Inc.: Cytokinetics Announces Clinic .. -1827452 to be Presented at the 2009 Annual Scien
[ Mon, Mar 23rd 2009 ] - Market Wire
Novogen, Limited: Board Changes at Novogen Limited Announced
[ Mon, Mar 23rd 2009 ] - Market Wire
Vicor Technologies, Inc.: Vicor Technologies Reta .. ameron Associates for Investor Relations Services
[ Mon, Mar 23rd 2009 ] - Market Wire
HearUSA: HearUSA Sets Fourth Quarter and Year End .. ference Call for Thursday, March 26 at 4:30 PM ET
[ Mon, Mar 23rd 2009 ] - Market Wire
Allana Resources Inc.: Analyst Coverage Initiated on Allana Resources
[ Mon, Mar 23rd 2009 ] - Market Wire
Skyepharma PLC: Skyepharma PLC Announces Regulatory Application
Fri, March 20, 2009
[ Fri, Mar 20th 2009 ] - Market Wire
MDRNA, Inc.: MDRNA, Inc. to Hold Year-End 2008 Ea .. uesday, March 24, 2009, at 8:30 a.m. Eastern Time
[ Fri, Mar 20th 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: William T. McKee Joins Board of Auxilium Pharmaceuticals, Inc.
Thu, March 19, 2009
[ Thu, Mar 19th 2009 ] - Market Wire
BioElectronics Corporation: BioElectronics to Pre .. ip and Health Tech Investment Forum on March 24th
[ Thu, Mar 19th 2009 ] - Market Wire
Midland Exploration Inc.: Midland Acquires New Gold Property Along the Destor-Porcupine Fault
[ Thu, Mar 19th 2009 ] - Market Wire
Chembio Diagnostics, Inc.: Chembio Reports 2008 Results
[ Thu, Mar 19th 2009 ] - Market Wire
Syneron Medical Ltd.: Syneron Dental Announces European OEM Agreement
[ Thu, Mar 19th 2009 ] - Market Wire
PDL BioPharma: PDL BioPharma Announces Conversion .. % Convertible Subordinated Notes Due August 16, 2
[ Thu, Mar 19th 2009 ] - Market Wire
Clariant AG: Clariant Appoints Mathias Lütgendorf Member of the Executive Committee
Wed, March 18, 2009
[ Wed, Mar 18th 2009 ] - Market Wire
CV Therapeutics, Inc.: CV Therapeutics' Board of .. ders Accept Gilead Sciences' $20.00 per Share Cas
[ Wed, Mar 18th 2009 ] - Market Wire
Marani Brands, Inc.: Marani Vodka Spirit Awarded .. 9 by The American Academy of Hospitality Sciences
[ Wed, Mar 18th 2009 ] - Market Wire
Marshall Edwards, Inc.: Triphendiol Safety Data C .. Be Studied Further in the Treatment of Pancreati
[ Wed, Mar 18th 2009 ] - Market Wire
Vicor Technologies, Inc.: Vicor Technologies Begi .. Study Under Research Agreement With University o
[ Wed, Mar 18th 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. icals to Present at Citi's 4th Annual Biotech Day
[ Wed, Mar 18th 2009 ] - Market Wire
Cypress Bioscience, Inc.: Cypress Bioscience, Inc .. en and Company 29th Annual Health Care Conference
Tue, March 17, 2009
[ Tue, Mar 17th 2009 ] - Market Wire
IDO Security, Inc.: IDO Security Announces Delivery of MagShoe to Multiple Clients
[ Tue, Mar 17th 2009 ] - Market Wire
Nanobac Pharmaceuticals: Nanobac Pharmaceuticals and Eureka Genomics Agree to Terms for Merger
[ Tue, Mar 17th 2009 ] - Market Wire
Edwards Lifesciences: Edwards Lifesciences Comple .. l Study Arm of U.S. Clinical Trial for Transcathe
[ Tue, Mar 17th 2009 ] - Market Wire
BioElectronics Corporation: BioElectronics Announces Menstrual Pain Clinical Study
[ Tue, Mar 17th 2009 ] - Market Wire
Chembio Diagnostics, Inc.: Chembio to Host Conference Call to Discuss 2008 Financial Results
[ Tue, Mar 17th 2009 ] - Market Wire
Eurand N.V.: Eurand Announces International Agree .. s for Once-Daily Extended Release Muscle Relaxant
Mon, March 16, 2009
[ Mon, Mar 16th 2009 ] - Market Wire
BIOLASE Technology, Inc.: BIOLASE Reports Fourth Quarter, Year-End Results
[ Mon, Mar 16th 2009 ] - Market Wire
Facet Biotech: Facet Biotech Provides 2009 Financial Guidance and Lowers Cash Utilization Estimate
[ Mon, Mar 16th 2009 ] - Market Wire
CV Therapeutics, Inc.: CV Therapeutics Announces .. College of Cardiology 58th Annual Scientific Ses
[ Mon, Mar 16th 2009 ] - Market Wire
Lakeland Industries, Inc.: EdgeWater Research Inv .. Highlights Lakeland Industries as Featured Stock
[ Mon, Mar 16th 2009 ] - Market Wire
Molecular Insight Pharmaceuticals, Inc. : Molecul .. nc. Announces Fourth Quarter and Year-End 2008 Fi
[ Mon, Mar 16th 2009 ] - Market Wire
Cypress Bioscience: Cypress Bioscience, Inc. Announces 2008 Financial Results
Sun, March 15, 2009
[ Sun, Mar 15th 2009 ] - Market Wire
Diagnostic Imaging International Corp.: Diagnosti .. ernational Corp.-Closes Acquisition and Financing
[ Sun, Mar 15th 2009 ] - Market Wire
FORTIS: Fortis holding pays no dividend for the 2008 financial year
[ Sun, Mar 15th 2009 ] - Market Wire
FORTIS: Memorandum of Understanding Between Fortis and Ping An Expired
Fri, March 13, 2009
[ Fri, Mar 13th 2009 ] - Market Wire
Midland Exploration Inc.: Midland Exploration Inc.: Amendment to Stock Option Plan
[ Fri, Mar 13th 2009 ] - Market Wire
SCOR: Standard & Poor's upgrades SCOR to "A"
[ Fri, Mar 13th 2009 ] - Market Wire
Molecular Insight Pharmaceuticals, Inc. : Molecul .. nc. to Announce Fourth Quarter, Year-End 2008 Fin
[ Fri, Mar 13th 2009 ] - Market Wire
San Anton Resource Corporation: San Anton Announces Kings Minerals Share Purchase Plan Offer
[ Fri, Mar 13th 2009 ] - Market Wire
Lpath, Inc.: Lpath to Hire Clinical Head
[ Fri, Mar 13th 2009 ] - Market Wire
MoneyTV; Hydrogen Hybrid Corporation; AlphaTrade. .. ; Cord Blood America, Inc.: MoneyTV, Week of 3/13
Thu, March 12, 2009
[ Thu, Mar 12th 2009 ] - Market Wire
Pacific Energy Resources Ltd.: Court Enters Order .. Trading in Stock of Pacific Energy Resources Ltd.
[ Thu, Mar 12th 2009 ] - Market Wire
Sanguine Corporation: Sanguine Corp Announces Let .. mmitment to License PHER-O2 to Rockland Technimed
[ Thu, Mar 12th 2009 ] - Market Wire
Pacific Energy Resources Ltd.: TSX Suspends Trading; Subsequent Delisting
[ Thu, Mar 12th 2009 ] - Market Wire
AspenBio Pharma, Inc.: AspenBio Pharma to Host Investor Update Call Today at 4:30 PM ET
[ Thu, Mar 12th 2009 ] - Market Wire
Urigen Pharmaceuticals: Urigen Pharmaceuticals, I .. rey G. Proctor, M.D. to Scientific Advisory Board
[ Thu, Mar 12th 2009 ] - Market Wire
Electro-Optical Sciences, Inc.: Electro-Optical S .. Data From MelaFind(R) Pivotal Study Presented at
Wed, March 11, 2009
[ Wed, Mar 11th 2009 ] - Market Wire
Molecular Insight Pharmaceuticals, Inc. : Molecul .. Protocol Assessment Approval From FDA for Phase 2
[ Wed, Mar 11th 2009 ] - Market Wire
PDL BioPharma: PDL BioPharma Elects Frederick Frank and Jody Lindell to Its Board of Directors
[ Wed, Mar 11th 2009 ] - Market Wire
DUSA Pharmaceuticals, Inc.: DUSA Pharmaceuticals .. ll Year 2008 Corporate Highlights and Financial R
Tue, March 10, 2009
[ Tue, Mar 10th 2009 ] - Market Wire
Watson Pharmaceuticals: Watson to Present at Cowen and Company 29th Annual Health Care Conference
[ Tue, Mar 10th 2009 ] - Market Wire
Trinity Biotech: Trinity Biotech Announces Quarter 4 Results
[ Tue, Mar 10th 2009 ] - Market Wire
Allana Resources Inc.: Allana Resources Appoints .. a Biya Senior Vice President Business Development
[ Tue, Mar 10th 2009 ] - Market Wire
Vyteris, Inc.: Vyteris Initiates Phase II Clinica .. nfertility Treatment Using Smart Patch Technology
[ Tue, Mar 10th 2009 ] - Market Wire
Eurand N.V.: FDA Grants Orphan Drug Designation for EUR-1073
[ Tue, Mar 10th 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. en and Company 29th Annual Health Care Conference
Mon, March 9, 2009
[ Mon, Mar 09th 2009 ] - Market Wire
Trinity Biotech: Trinity Biotech Announces Commencement of TRI-stat(TM) CLIA Trials
[ Mon, Mar 09th 2009 ] - Market Wire
XELR8 Holdings, Inc.: XELR8 Holdings Begins Trading Under New Symbol XELR
[ Mon, Mar 09th 2009 ] - Market Wire
Wellstar International, Inc.: Wellstar International, Inc. Secures $250,000 of New Financing
[ Mon, Mar 09th 2009 ] - Market Wire
Human Genome Sciences, Inc.: Human Genome Science .. in Second of Two Phase 3 Trials of Albuferon(R) i
[ Mon, Mar 09th 2009 ] - Market Wire
SciClone Pharmaceuticals, Inc.: SciClone Complete .. e in Phase 2 Trial for RP101 in Late-Stage Pancre
[ Mon, Mar 09th 2009 ] - Market Wire
Cypress Bioscience, Inc.: Cypress Bioscience, Inc .. at Barclays Capital Global Healthcare Conference
Fri, March 6, 2009
[ Fri, Mar 06th 2009 ] - Market Wire
SCOR: SCOR announces the publication of its 2008 Registration Document
[ Fri, Mar 06th 2009 ] - Market Wire
DUSA Pharmaceuticals, Inc.: DUSA Pharmaceuticals, .. er and Full Year 2008 Financial Results and Corpo
[ Fri, Mar 06th 2009 ] - Market Wire
MDRNA, Inc.: MDRNA, Inc. Receives Delisting Notice From NASDAQ and Requests Hearing
[ Fri, Mar 06th 2009 ] - Market Wire
Trinity Biotech: Trinity Biotech plc to Announce .. uarter and Fiscal 2008 Year-End Financial Results
[ Fri, Mar 06th 2009 ] - Market Wire
Skyepharma PLC: Skyepharma PLC announces Conversion of Bonds
[ Fri, Mar 06th 2009 ] - Market Wire
Asher Xino Corporation: AsherXino Corporation Appoints Jack Webb Vice Chairman
Thu, March 5, 2009
[ Thu, Mar 05th 2009 ] - Market Wire
BIOLASE Technology, Inc.: BIOLASE Announces Appointment of David Mulder to CEO
[ Thu, Mar 05th 2009 ] - Market Wire
Cord Blood America: Cord Blood America Top Stock .. Global Stem Cell and Regenerative Medicine Index
[ Thu, Mar 05th 2009 ] - Market Wire
Skyepharma PLC: Skyepharma PLC announces Consultation Process
[ Thu, Mar 05th 2009 ] - Market Wire
CV Therapeutics, Inc.: CV Therapeutics Reports Ph .. Concept for CVT-3619, a Novel Potential Treatment
[ Thu, Mar 05th 2009 ] - Market Wire
Eurand N.V.: Eurand Reports Recent Developments a .. urth Quarter and Full-Year 2008 Financial Results
Wed, March 4, 2009
[ Wed, Mar 04th 2009 ] - Market Wire
Wellstar International, Inc.: Wellstar Internatio .. l, Inc. Signs LOI for up to $1 Million in Funding
[ Wed, Mar 04th 2009 ] - Market Wire
Constellation Software Inc.: Constellation Softwa .. the Fourth Quarter and Year Ended December 31, 2
[ Wed, Mar 04th 2009 ] - Market Wire
Trinity Biotech: Trinity Biotech Announces Its Fi .. st 3 Destiny Max Placements in the United Kingdom
[ Wed, Mar 04th 2009 ] - Market Wire
Eurand N.V.: Eurand to Present at Cowen Health Care Conference
[ Wed, Mar 04th 2009 ] - Market Wire
Syneron Medical Ltd.: Syneron(TM) Unveils New eMa .. ctional Treatments for Darker Skin Types at Ameri
[ Wed, Mar 04th 2009 ] - Market Wire
AVI BioPharma, Inc.: AVI BioPharma Announces Four .. d Year End 2008 Financial Results Conference Call
Tue, March 3, 2009
[ Tue, Mar 03rd 2009 ] - Market Wire
SCOR: SCOR records solid results with a net incom .. ed by an outstanding liquidity position of EUR 3.
[ Tue, Mar 03rd 2009 ] - Market Wire
XELR8 Holdings, Inc.: XELR8 Holdings Loses Appeal at the NYSE Alternext
[ Tue, Mar 03rd 2009 ] - Market Wire
Anaconda Mining Inc.: Anaconda Announces Initiati .. of Arbitration Process With JV Partner New Island
[ Tue, Mar 03rd 2009 ] - Market Wire
Given Imaging: Given Imaging Sets Dividend Distribution Date
[ Tue, Mar 03rd 2009 ] - Market Wire
FONAR Corporation: FONAR Enters Africa and Middle .. kets With Sale to Leading Medical Center in Libya
[ Tue, Mar 03rd 2009 ] - Market Wire
SciClone Pharmaceuticals, Inc.: SciClone Reports .. Results for the Fourth Quarter and Year-End 2008
Mon, March 2, 2009
[ Mon, Mar 02nd 2009 ] - Market Wire
Wellstar International, Inc.: Wellstar/TMI to Uti .. Board Members in the Marketing of Imaging Systems
[ Mon, Mar 02nd 2009 ] - Market Wire
PDL BioPharma: PDL BioPharma Announces Fourth Quarter and Full Year 2008 Financial Results
[ Mon, Mar 02nd 2009 ] - Market Wire
NeuroInvestment: Migraine Therapeutics Reviewed by NeuroInvestment
[ Mon, Mar 02nd 2009 ] - Market Wire
Hansen Medical, Inc.: Hansen Medical Announces St .. anced Cardiac Therapeutics and Procurement of Cer
[ Mon, Mar 02nd 2009 ] - Market Wire
Watson Pharmaceuticals: Watson to Present at Barclays Capital Global Healthcare Conference
[ Mon, Mar 02nd 2009 ] - Market Wire
Targeted Genetics: Targeted Genetics Provides Business Update and Announces Extended Cash Horizon
Fri, February 27, 2009
[ Fri, Feb 27th 2009 ] - Market Wire
Nanobac Pharmaceuticals: Nanobac Message to Shareholders
[ Fri, Feb 27th 2009 ] - Market Wire
CONMED Corporation: CONMED Corporation Sets Annual Meeting Date
[ Fri, Feb 27th 2009 ] - Market Wire
BIOLASE Technology, Inc.: BIOLASE Launches New Wa .. se(R) MD Turbo(TM) All-Tissue Dental Laser System
[ Fri, Feb 27th 2009 ] - Market Wire
EPIX Pharmaceuticals Announces Resignation of Chief Business Officer
[ Fri, Feb 27th 2009 ] - Market Wire
Panacos Announces Voluntary Decision to Delist Co .. aq and Terminate SEC Registration of Common Stock
[ Fri, Feb 27th 2009 ] - Market Wire
Alexion Joins NORD and EURORDIS in Supporting the Goals of Rare Disease Day
Thu, February 26, 2009
[ Thu, Feb 26th 2009 ] - Market Wire
European Authorities Approve Larger-Scale Production of Genzyme?s Myozyme
[ Thu, Feb 26th 2009 ] - Market Wire
A Senior Cancer Researcher Joins PhytoMedical on .. uccessful Preclinical Study on Human Brain Cancer
[ Thu, Feb 26th 2009 ] - Market Wire
70 Abstracts Evaluatingthe Potential of Celgene P .. Be Presented at the 12th International Myeloma W
[ Thu, Feb 26th 2009 ] - Market Wire
Conceptus Appoints John L. Bishop to Board of Directors
[ Thu, Feb 26th 2009 ] - Market Wire
Natus Medical Announces Record 2008 Fourth Quarter and Full Year Results
[ Thu, Feb 26th 2009 ] - Market Wire
Zacks Bull & Bear of the Day Highlights: Pozen In .. Corp., Agrium, CF Industries and Terra Industries
Wed, February 25, 2009
[ Wed, Feb 25th 2009 ] - Market Wire
Anika Therapeutics Announces Date of Fourth Quart .. d Year End 2008 Financial Results Conference Call
[ Wed, Feb 25th 2009 ] - Market Wire
Dyax Corp. Announces Fourth Quarter and Year End 2008 Financial Results
[ Wed, Feb 25th 2009 ] - Market Wire
Adipose-Derived Stem and Regenerative Cells Preve .. ity and Reduce Kidney Damage in Preclinical Study
[ Wed, Feb 25th 2009 ] - Market Wire
Ceragenix and Pediapharm Enter Into Distribution and Supply Agreement for EpiCeram®
[ Wed, Feb 25th 2009 ] - Market Wire
A.P. Pharma Appoints John B. Whelan as Chief Financial Officer
[ Wed, Feb 25th 2009 ] - Market Wire
Zacks Industry Outlook Highlights: Immucor
Tue, February 24, 2009
[ Tue, Feb 24th 2009 ] - Market Wire
HemaCare Corporation: HemaCare Reports Record 4th Quarter and 2008 Revenues
[ Tue, Feb 24th 2009 ] - Market Wire
Free Electronic Prescribing Service Now Available to San Antonio Physicians
[ Tue, Feb 24th 2009 ] - Market Wire
Assisted Living Concepts, Inc.: Assisted Living C .. Fourth Quarter and Full Year Results -- Solid Fou
[ Tue, Feb 24th 2009 ] - Market Wire
Resumen: Biogen Idec nombra a Michael Lytton vicepresidente ejecutivo de desarrollo empresarial
[ Tue, Feb 24th 2009 ] - Market Wire
Bioject Enters into a Collaborative Research Agre .. IAVI for the Delivery of an HIV Vaccine Candidate
Mon, February 23, 2009
[ Mon, Feb 23rd 2009 ] - Market Wire
Celldex to Report Fourth Quarter and Fiscal 2008 Financial Results on February 27, 2009
[ Mon, Feb 23rd 2009 ] - Market Wire
Home Diagnostics to Report Fourth Quarter and Full Year 2008 Financial Results on March 3, 2009
[ Mon, Feb 23rd 2009 ] - Market Wire
Medical Nutrition USA Inc.: Coverage Initiated on Medical Nutrition USA Inc.
[ Mon, Feb 23rd 2009 ] - Market Wire
Daxor Corp.: Daxor Announces Fresno Heart & Surgi .. Fresno, CA Acquires BVA-100 Blood Volume Analyzer
[ Mon, Feb 23rd 2009 ] - Market Wire
MDRNA, Inc.: MDRNA Successfully Silences Gene Tar .. ts in Animal Models Using Novel UsiRNA Constructs

Skyepharma PLC: Skyepharma PLC announces Conversion of Bonds


//health-fitness.news-articles.net/content/2009/ .. kyepharma-plc-announces-conversion-of-bonds.html
Published in Health and Fitness on Friday, March 6th 2009 at 5:13 GMT, Last Modified on 2009-03-06 05:14:23 by Market Wire   Print publication without navigation


LONDON--(Marketwire - March 6, 2009) - 

 Conversion of GBP1,613,000 6% 2024 Bonds LONDON, UK, 6 March 2009 -- SkyePharma PLC (LSE: SKP) today announces that it has received notification in respect of GBP1,613,000 of the 6% 2024 Convertible Bonds ("Bonds") to convert them into ordinary shares of GBP1.00 each ("Ordinary Shares"). In accordance with the terms of the Bonds, the conversion will take place at the exchange price of GBP3.71 per share and, following completion of the exchange process, will result in the issue of an additional 434,770 Ordinary Shares. The reduction in debt will reduce finance costs by GBP96,780 per annum and strengthen the Group's balance sheet. Application will be made to the UK Listing Authority and to the London Stock Exchange for the additional Ordinary Shares to be admitted to the Official List. The additional Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares and when issued and allotted the total issued share capital of the Company will be 22,602,734 Ordinary Shares. For further information please contact: SkyePharma PLC Ken Cunningham +44 20 7491 1777 Peter Grant Financial Dynamics David Yates +44 20 7831 3113 Jonathan Birt About SkyePharma PLC Using its proprietary drug delivery technologies, SkyePharma develops new formulations of existing products to provide a clinical advantage and life-cycle extension. The Company has twelve approved products in the areas of oral, inhalation and topical delivery. The Group's products are marketed throughout the world by leading pharmaceutical companies. For more information, visit [ www.skyepharma.com ]. This information is provided by RNS The company news service from the London Stock Exchange END


Publication Contributing Sources